Gilead Sciences, Inc.GILDNASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank50
3Y CAGR+14.3%
5Y CAGR+19.5%
Year-over-Year Change
Operating income as a percentage of revenue
3Y CAGR
+14.3%/yr
vs -7.7%/yr prior
5Y CAGR
+19.5%/yr
Recent deceleration
Acceleration
+22.0pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 40.14% | +594.4% |
| 2024 | 5.78% | -79.4% |
| 2023 | 28.05% | +4.4% |
| 2022 | 26.87% | -26.0% |
| 2021 | 36.32% | +120.3% |
| 2020 | 16.49% | -13.7% |
| 2019 | 19.10% | -48.5% |
| 2018 | 37.06% | -31.5% |
| 2017 | 54.10% | -6.8% |
| 2016 | 58.02% | - |